TAERTAB
Live / Registered — Registered (as of 22 Apr 2025)
What this means for you
Registered since 22 Apr 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90725772
- Registration number
- 7770284
- Mark type
- Stylized text
- Filed
- 20 May 2021
- Published for opposition
- 26 Oct 2021
- Registered
- 22 Apr 2025
- Attorney of record
- Kongsik Kim
Goods and services
- Class 042 — Scientific and technological services: Research and development of pharmaceuticals for others; Research and development of pharmaceuticals for others related to cancer; Medical research; Medical laboratories; Medical and scientific research in the field of cancer; Clinical research in the field of cancer; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Compiling data for research purposes in the field of medical science and medical consultancy
Owner
- Pinetree Therapeutics, Inc., Cambridge, MA, US
- Pinetree Therapeutics, Inc., Cambridge, MA, US
- Pinetree Therapeutics, Inc., Cambridge, MI, US
Prosecution history
- 22 Apr 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 22 Apr 2025 — REGISTERED-PRINCIPAL REGISTER
- 31 Mar 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 31 Mar 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 04 Mar 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 20 Dec 2024 — USE AMENDMENT FILED
- 04 Mar 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 20 Dec 2024 — TEAS STATEMENT OF USE RECEIVED
- 20 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Jun 2024 — SOU EXTENSION 5 GRANTED
- 21 Jun 2024 — SOU EXTENSION 5 FILED
- 20 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 23 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 21 Dec 2023 — SOU EXTENSION 4 GRANTED
- 21 Dec 2023 — SOU EXTENSION 4 FILED